Advisory Board

Dr. Aubrey de Grey

Dr. Aubrey de Grey, Ph.D., FGSA is coauthor of Ending Aging: The Rejuvenation Breakthroughs That Could Reverse Human Aging in Our Lifetime. He earned his Ph.D. in Biology at the University of Cambridge in the United Kingdom and is Chairman and Chief Science Officer of the Methuselah Foundation.
 
He is the Editor-in-Chief of Rejuvenation Research, and is on the editorial board of the publications Mitochondrion, AGE (Journal of the American Aging Association), and Current Stem Cell Research & Therapy.
 
Aubrey is on the Scientific Advisory Boards of the Supercentenarian Research Foundation, Maximum Life Foundation, Legendary Pharmaceuticals, the Centenarian Species and Rockfish project, the Alcor Life Extension Foundation, the Singularity Institute for Artificial Intelligence, the Foresight Institute, and Biomind LLC.
 
Aubrey is on the board of directors of the International Association of Biomedical Gerontology and of the American Aging Association. He is a fellow with The Gerontological Society of America.
 
The central goal of Dr. Aubrey de Grey’s biogerontology work is to expedite the development of a true cure for human aging. He says “The main obstacle to developing such technology is the position of biogerontology at the boundary between basic science and medicine: the fundamental knowledge necessary to develop truly effective anti-aging medicine mostly exists, but the goal-directed frame of mind that is best suited to turning research findings into tools is very different from the curiosity-driven ethos that generated those findings in the first place.”
 
See him with 60 Minutes correspondent Morley Safer! Watch his TEDTalk Might we all live 100 years longer? 1000?. Listen to him on Fast Forward Radio and The Future And You.
 
Aubrey was a peer expert reader of the entire manuscript of Fantastic Voyage : Live Long Enough to Live Forever, authored by Ray Kurzweil and Terry Grossman.